156 related articles for article (PubMed ID: 36104324)
1. Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties.
Bonneaud TL; Lefebvre CC; Nocquet L; Basseville A; Roul J; Weber H; Campone M; Juin PP; Souazé F
Cell Death Dis; 2022 Sep; 13(9):787. PubMed ID: 36104324
[TBL] [Abstract][Full Text] [Related]
2. Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers.
Louault K; Bonneaud TL; Séveno C; Gomez-Bougie P; Nguyen F; Gautier F; Bourgeois N; Loussouarn D; Kerdraon O; Barillé-Nion S; Jézéquel P; Campone M; Amiot M; Juin PP; Souazé F
Oncogene; 2019 Apr; 38(17):3261-3273. PubMed ID: 30631150
[TBL] [Abstract][Full Text] [Related]
3. Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.
Romano V; Ruocco MR; Carotenuto P; Barbato A; Venuta A; Acampora V; De Lella S; Vigliar E; Iaccarino A; Troncone G; Calì G; Insabato L; Russo D; Franco B; Masone S; Velotti N; Accurso A; Pellegrino T; Fiume G; Belviso I; Montagnani S; Avagliano A; Arcucci A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743318
[TBL] [Abstract][Full Text] [Related]
4. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
7. The Interaction Between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer.
Maeda A; Takahashi H; Harata S; Watanabe K; Yanagita T; Suzuki T; Ushigome H; Nakai N; Maeda Y; Hirokawa T; Shiga K; Ogawa R; Hara M; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Anticancer Res; 2022 Mar; 42(3):1277-1288. PubMed ID: 35220217
[TBL] [Abstract][Full Text] [Related]
8. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
9. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo.
Mitchell C; Yacoub A; Hossein H; Martin AP; Bareford MD; Eulitt P; Yang C; Nephew KP; Dent P
Cancer Biol Ther; 2010 Nov; 10(9):903-17. PubMed ID: 20855960
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.
Anderson GR; Wardell SE; Cakir M; Crawford L; Leeds JC; Nussbaum DP; Shankar PS; Soderquist RS; Stein EM; Tingley JP; Winter PS; Zieser-Misenheimer EK; Alley HM; Yllanes A; Haney V; Blackwell KL; McCall SJ; McDonnell DP; Wood KC
Sci Transl Med; 2016 Dec; 8(369):369ra175. PubMed ID: 27974663
[TBL] [Abstract][Full Text] [Related]
12. Stromal integrin α11 regulates PDGFR-β signaling and promotes breast cancer progression.
Primac I; Maquoi E; Blacher S; Heljasvaara R; Van Deun J; Smeland HY; Canale A; Louis T; Stuhr L; Sounni NE; Cataldo D; Pihlajaniemi T; Pequeux C; De Wever O; Gullberg D; Noel A
J Clin Invest; 2019 Jul; 129(11):4609-4628. PubMed ID: 31287804
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Eiro N; González L; Martínez-Ordoñez A; Fernandez-Garcia B; González LO; Cid S; Dominguez F; Perez-Fernandez R; Vizoso FJ
Cell Oncol (Dordr); 2018 Aug; 41(4):369-378. PubMed ID: 29497991
[TBL] [Abstract][Full Text] [Related]
14. Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.
Williams MM; Lee L; Hicks DJ; Joly MM; Elion D; Rahman B; McKernan C; Sanchez V; Balko JM; Stricker T; Estrada MV; Cook RS
Mol Cancer Res; 2017 Mar; 15(3):259-268. PubMed ID: 28039357
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Breast Cancer-Associated Fibroblasts in Tumor Development, Therapy Resistance and Evaluation of Potential Therapeutic Strategies.
Ruocco MR; Avagliano A; Granato G; Imparato V; Masone S; Masullo M; Nasso R; Montagnani S; Arcucci A
Curr Med Chem; 2018; 25(29):3414-3434. PubMed ID: 29521203
[TBL] [Abstract][Full Text] [Related]
16. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.
Cao Y; Cao W; Qiu Y; Zhou Y; Guo Q; Gao Y; Lu N
Pharmacol Res; 2020 Sep; 159():104981. PubMed ID: 32492489
[TBL] [Abstract][Full Text] [Related]
17. Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.
Barone I; Vircillo V; Giordano C; Gelsomino L; Győrffy B; Tarallo R; Rinaldi A; Bruno G; Caruso A; Romeo F; Bonofiglio D; Andò S; Catalano S
Cancer Lett; 2018 Nov; 437():89-99. PubMed ID: 30176263
[TBL] [Abstract][Full Text] [Related]
18. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts.
Wan X; Guan S; Hou Y; Qin Y; Zeng H; Yang L; Qiao Y; Liu S; Li Q; Jin T; Qiu Y; Liu M
Theranostics; 2021; 11(10):4975-4991. PubMed ID: 33754039
[TBL] [Abstract][Full Text] [Related]
19. Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.
Chang YH; Ngo NH; Vuong CK; Yamashita T; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2022 Nov; 31(21-22):659-671. PubMed ID: 35734905
[TBL] [Abstract][Full Text] [Related]
20. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
